Here’s how I came up with my $500M valuation (which, is quite possibly very conservative):
OWCP has NO TOXIC DEBT. That was announced in an 8-K back in October. (This isn’t some OTC Pink Sheet operation.) They have real investors. That same October 8-K talks about a $300,000 non-interest bearing loan. They have royalty-based distribution deals with MedMar and Michepro, because the distributor obviously has confidence too.